Terrien EF - Search Results

1

Relation of leukocytosis to C-reactive protein and interleukin-6 among patients undergoing percutaneous coronary intervention.

Gogo PB Jr, Schneider DJ, Terrien EF, Watkins MW, Sobel BE, Dauerman HL. Gogo PB Jr, et al. Among authors: terrien ef. Am J Cardiol. 2005 Aug 15;96(4):538-42. doi: 10.1016/j.amjcard.2005.04.016. Am J Cardiol. 2005. PMID: 16098308

2

Suboptimal early inhibition of platelets by treatment with tirofiban and implications for coronary interventions.

Kabbani SS, Aggarwal A, Terrien EF, DiBattiste PM, Sobel BE, Schneider DJ. Kabbani SS, et al. Among authors: terrien ef. Am J Cardiol. 2002 Mar 1;89(5):647-50. doi: 10.1016/s0002-9149(01)02319-0. Am J Cardiol. 2002. PMID: 11867064 No abstract available.

3

Usefulness of platelet reactivity before percutaneous coronary intervention in determining cardiac risk one year later.

Kabbani SS, Watkins MW, Ashikaga T, Terrien EF, Sobel BE, Schneider DJ. Kabbani SS, et al. Among authors: terrien ef. Am J Cardiol. 2003 Apr 1;91(7):876-8. doi: 10.1016/s0002-9149(03)00025-0. Am J Cardiol. 2003. PMID: 12667577 No abstract available.

4

Comparison of effects of abciximab versus eptifibatide on C-reactive protein, interleukin-6, and interleukin-1 receptor antagonist after coronary arterial stenting.

Aggarwal A, Schneider DJ, Terrien EF, Terrien CM Jr, Sobel BE, Dauerman HL. Aggarwal A, et al. Among authors: terrien ef. Am J Cardiol. 2003 Jun 1;91(11):1346-9. doi: 10.1016/s0002-9149(03)00327-8. Am J Cardiol. 2003. PMID: 12767431 Clinical Trial. No abstract available.

5

Increase in interleukin-6 in the first hour after coronary stenting: an early marker of the inflammatory response.

Aggarwal A, Schneider DJ, Terrien EF, Gilbert KE, Dauerman HL. Aggarwal A, et al. Among authors: terrien ef. J Thromb Thrombolysis. 2003 Feb;15(1):25-31. doi: 10.1023/a:1026188200939. J Thromb Thrombolysis. 2003. PMID: 14574073 Clinical Trial.

6

Increased coronary arterial release of interleukin-1 receptor antagonist and soluble CD40 ligand indicative of inflammation associated with culprit coronary plaques.

Aggarwal A, Schneider DJ, Terrien EF, Sobel BE, Dauerman HL. Aggarwal A, et al. Among authors: terrien ef. Am J Cardiol. 2004 Jan 1;93(1):6-9. doi: 10.1016/j.amjcard.2003.09.003. Am J Cardiol. 2004. PMID: 14697457

7

Systemic inflammation after drug-eluting stent placement.

Gogo PB Jr, Schneider DJ, Watkins MW, Terrien EF, Sobel BE, Dauerman HL. Gogo PB Jr, et al. Among authors: terrien ef. J Thromb Thrombolysis. 2005 Apr;19(2):87-92. doi: 10.1007/s11239-005-1378-6. J Thromb Thrombolysis. 2005. PMID: 16052297 Clinical Trial.

8

Osteoprotegerin is not associated with angiographic coronary calcification.

Gogo PB Jr, Schneider DJ, Terrien EF, Sobel BE, Dauerman HL. Gogo PB Jr, et al. Among authors: terrien ef. J Thromb Thrombolysis. 2006 Dec;22(3):177-83. doi: 10.1007/s11239-006-9026-3. J Thromb Thrombolysis. 2006. PMID: 17111200

9

Extravascular closure for patients with high-risk femoral anatomy.

Rashid MN, Ahmed B, Straight F, Bradley JT, Gilbert K, Gogo PB, Terrien EF, Watkins MW, Dauerman HL. Rashid MN, et al. Among authors: terrien ef. J Invasive Cardiol. 2008 Jul;20(7):328-32. J Invasive Cardiol. 2008. PMID: 18599888

10

Platelet reactivity characterized prospectively: a determinant of outcome 90 days after percutaneous coronary intervention.

Kabbani SS, Watkins MW, Ashikaga T, Terrien EF, Holoch PA, Sobel BE, Schneider DJ. Kabbani SS, et al. Among authors: terrien ef. Circulation. 2001 Jul 10;104(2):181-6. doi: 10.1161/01.cir.104.2.181. Circulation. 2001. PMID: 11447083 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters